Intraocular Concentrations of Cytokines and Chemokines in a Unique Case of Nivolumab-Induced Uveitis

Masaaki Yoshida1 Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan

, MD,

Hiroshi Kunikata1 Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan;2 Department of Retinal Disease Control, Tohoku University Graduate School of Medicine, Sendai, JapanCorrespondence[email protected]

, MD, PhD &

Toru Nakazawa1 Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan;2 Department of Retinal Disease Control, Tohoku University Graduate School of Medicine, Sendai, Japan;3 Department of Ophthalmic Imaging and Information Analytics, Tohoku University Graduate School of Medicine, Sendai, Japan;4 Department of Advanced Ophthalmic Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan

, MD, PhD

REFERENCES

Conrady CD, Larochelle M, Pecen P, Palestine A, Shakoor A, Singh A. Checkpoint inhibitor-induced uveitis: a case series. Graefe’s Arch Clin Exp Ophthalmol. 2018;256(1):187–191. doi:10.1007/s00417-017-3835-2.
PubMed Web of Science ®Google Scholar
Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
PubMed Web of Science ®Google Scholar
Aketa N, Yamaguchi T, Suzuki T, et al. Iris damage is associated with elevated cytokine levels in aqueous humor. Invest Ophthalmol Vis Sci. 2017;58(6):BIO42–BIO51. doi:10.1167/iovs.17-21421.
PubMed Web of Science ®Google Scholar
Theillac C, Straub M, Breton AL, Thomas L, Dalle S. Bilateral uveitis and macular edema induced by Nivolumab: A case report. BMC Ophthalmol. 2017;17(1):1–4. doi:10.1186/s12886-016-0396-9.
PubMedGoogle Scholar
Zhang H, Watanabe R, Berry GJ, et al. Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis. Proc Natl Acad Sci. 2017;114(6):E970–E979.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Intraocular Concentrations of Cytokines and Chemokines in a Unique Case of Nivolumab-Induced Uveitis

REFERENCES

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Intraocular Concentrations of Cytokines and Chemokines in a Unique Case of Nivolumab-Induced Uveitis

REFERENCES

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date